Achiko AG (XSWX:ACHI) Change In Receivables : CHF0.00 Mil (TTM As of Jun. 2022)

View and export this data going back to 2019. Start your Free Trial

What is Achiko AG Change In Receivables?

Achiko AG's change in receivables for the quarter that ended in Jun. 2022 was CHF0.00 Mil. It means Achiko AG's Accounts Receivable stayed the same from Dec. 2021 to Jun. 2022 .

Achiko AG's change in receivables for the fiscal year that ended in Dec. 2021 was CHF0.00 Mil. It means Achiko AG's Accounts Receivable stayed the same from Dec. 2020 to Dec. 2021 .

Achiko AG's Accounts Receivable for the quarter that ended in Jun. 2022 was CHF0.01 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Achiko AG's liquidation value for the six months ended in Jun. 2022 was CHF-8.92 Mil.

Achiko AG Change In Receivables Historical Data

The historical data trend for Achiko AG's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Achiko AG Change In Receivables Chart

Achiko AG Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Change In Receivables

Achiko AG Semi-Annual Data
	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22
Change In Receivables	Get a 7-Day Free Trial			-	-	-	-	-

Achiko AG Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jun. 2022 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF0.00 Mil.

Achiko AG (XSWX:ACHI) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Achiko AG's Days Sales Outstanding for the quarter that ended in Jun. 2022 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0.005	/	0	*	91
=

2. In Ben Graham's calculation of liquidation value, Achiko AG's accounts receivable are only considered to be worth 75% of book value:

Achiko AG's liquidation value for the quarter that ended in Jun. 2022 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	0.052	-	8.98	+	0.75 * 0.005	+	0.5 * 0
=	-8.92

Achiko AG Change In Receivables Related Terms

Thank you for viewing the detailed overview of Achiko AG's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Achiko AG (XSWX:ACHI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Achiko AG (XSWX:ACHI) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

Tessinerplatz 7, Zurich, CHE, CH-8002

Website

https://www.achiko.com

Achiko AG is developing disruptive diagnostic solutions that put people first. The company product is a rapid, reliable Covid-19 test with a companion app offering a user-friendly digital health passport. Achiko creates and develops aptamer-based diagnostics through its biotechnology division, AptameX, and companion health apps via its digital mobile health technology division, Teman Sehat. The AptameX DNA aptamer tests can be rapidly chemically synthesized, are cost-effective, and have wide potential across multiple disease diagnostics. Leveraging AptameX and Teman Sehat, Achiko aims to deliver fast, accurate, and affordable diagnostic testing for a range of pathogenic diseases and therapeutic indications in the rapidly evolving healthcare diagnostics field.

Achiko AG (XSWX:ACHI) Headlines

No Headlines